← Return to Pancreatic Cancer Recurrence after Whipple
DiscussionPancreatic Cancer Recurrence after Whipple
Pancreatic Cancer | Last Active: Aug 21 1:48pm | Replies (89)Comment receiving replies
Replies to "Hello Bethf, while I know it is tough to find out that the tumor marker tests..."
Thanks so much for your response. The requirements of the present study are that you have MRD as indicated by elevated tumor markers and a positive ctDNA test. You have to have been through first-line chemo and surgery. They actually rule you out from participation if you have a scan showing tumor or metastasis. It's a very small hole in the needle to fit through (as are most clinical trial requirements). Also, they are targeting the mutation I have, which is KRAS G-12d. Like I said, it's an almost impossible hole to fit through. The only criteria I did not meet was that I was ctDNA negative, but as of early February Signatera test, I have converted to ctDNA positive, which now qualifies me for the study. I have read the prospectus for the study and the complete Client Consent Form which are very detailed. So, I'm pretty certain that I qualify. Dr. Messersmith is reaching out to the team (he is the head of research here at UC Health Anschutz) and I will know tomorrow whether I qualify. I am glad that I have time to make a reasoned and planful decision. Thanks so much for your input.